Avalo Therapeutics Inc
F:C6K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
F:C6K
|
US |
|
A
|
Atmos Energy Corp
F:AEO
|
US |
|
Kone Oyj
F:KC40
|
FI |
|
United Fire Group Inc
NASDAQ:UFCS
|
US |
|
A
|
Allianz SE
F:ALV
|
DE |
|
Power Grid Corporation of India Ltd
BSE:532898
|
IN |
Wall St Price Targets
C6K Price Targets Summary
Avalo Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for C6K is 6.436 EUR with a low forecast of 4.692 EUR and a high forecast of 8.608 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C6K's stock price target?
Price Target
6.436
EUR
According to Wall Street analysts, the average 1-year price target for C6K is 6.436 EUR with a low forecast of 4.692 EUR and a high forecast of 8.608 EUR.
What is the Revenue forecast for Avalo Therapeutics Inc?
Projected CAGR
227%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 227%.
What is the Gross Profit forecast for Avalo Therapeutics Inc?
Projected CAGR
221%
The compound annual growth rate for Gross Profit over the next 8 years is 221%.
